{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:38:53Z","timestamp":1790959133064,"version":"4.1.0"},"reference-count":265,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T00:00:00Z","timestamp":1740441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundations of China","doi-asserted-by":"crossref","award":["82271123, 82071004 and 32200618"],"award-info":[{"award-number":["82271123, 82071004 and 32200618"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundations of China","doi-asserted-by":"crossref","award":["82271123, 82071004 and 32200618"],"award-info":[{"award-number":["82271123, 82071004 and 32200618"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Shanghai Key Clinical Specialty, Shanghai Eye Disease Research Center","award":["2022ZZ01003"],"award-info":[{"award-number":["2022ZZ01003"]}]},{"name":"National Key Research and Development Program of China","award":["2022YFA1105502"],"award-info":[{"award-number":["2022YFA1105502"]}]},{"name":"Science and Technology Commission of Shanghai","award":["20DZ2270800"],"award-info":[{"award-number":["20DZ2270800"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03095-6","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T16:09:01Z","timestamp":1740499741000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Frontier applications of retinal nanomedicine: progress, challenges and perspectives"],"prefix":"10.1186","volume":"23","author":[{"given":"Zhimin","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuxiang","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ni","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianqun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linna","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"issue":"2","key":"3095_CR1","doi-asserted-by":"publisher","first-page":"e130","DOI":"10.1016\/S2214-109X(20)30425-3","volume":"9","author":"R Bourne","year":"2021","unstructured":"Bourne R, et al. Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the global burden of disease study. Lancet Glob Health. 2021;9(2):e130\u201343.","journal-title":"Lancet Glob Health"},{"issue":"4","key":"3095_CR2","doi-asserted-by":"publisher","first-page":"e489","DOI":"10.1016\/S2214-109X(20)30488-5","volume":"9","author":"MJ Burton","year":"2021","unstructured":"Burton MJ, et al. The lancet global health commission on global eye health: vision beyond 2020. Lancet Glob Health. 2021;9(4):e489\u2013551.","journal-title":"Lancet Glob Health"},{"issue":"10414","key":"3095_CR3","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1016\/S0140-6736(23)01289-8","volume":"402","author":"H Jayaram","year":"2023","unstructured":"Jayaram H, et al. Glaucoma: now and beyond. Lancet. 2023;402(10414):1788\u2013801.","journal-title":"Lancet"},{"issue":"3","key":"3095_CR4","doi-asserted-by":"publisher","first-page":"eade9459","DOI":"10.1126\/sciadv.ade9459","volume":"9","author":"M Mercau","year":"2023","unstructured":"Mercau M, et al. MertkInflammation of the retinal pigment epithelium drives early-onset photoreceptor degeneration in -associated retinitis pigmentosa. Sci Adv. 2023;9(3):eade9459.","journal-title":"Sci Adv"},{"issue":"13","key":"3095_CR5","doi-asserted-by":"publisher","first-page":"3443","DOI":"10.1364\/OL.487260","volume":"48","author":"D Samanta","year":"2023","unstructured":"Samanta D, et al. High-resolution imaging of the whole eye with photoacoustic microscopy. Opt Lett. 2023;48(13):3443\u20136.","journal-title":"Opt Lett"},{"key":"3095_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2023.101220","volume":"98","author":"SK Szeto","year":"2024","unstructured":"Szeto SK, et al. Optical coherence tomography in the management of diabetic macular oedema. Prog Retin Eye Res. 2024;98: 101220.","journal-title":"Prog Retin Eye Res"},{"key":"3095_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2021.100965","volume":"85","author":"T Hormel","year":"2021","unstructured":"Hormel T, et al. Artificial intelligence in OCT angiography. Prog Retin Eye Res. 2021;85: 100965.","journal-title":"Prog Retin Eye Res"},{"key":"3095_CR8","doi-asserted-by":"crossref","unstructured":"Lee, B., et al., Wide-fitld three-dimensional depth-invariant cellular-resolution imaging of the human retina. Small, 2023: p. e2203357.","DOI":"10.1002\/smll.202203357"},{"issue":"7","key":"3095_CR9","doi-asserted-by":"publisher","first-page":"7823","DOI":"10.1021\/acsnano.9b08432","volume":"14","author":"GJ Lu","year":"2020","unstructured":"Lu GJ, et al. Genetically encodable contrast agents for optical coherence tomography. ACS Nano. 2020;14(7):7823\u201331.","journal-title":"ACS Nano"},{"issue":"2","key":"3095_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202204994","volume":"35","author":"H Gao","year":"2023","unstructured":"Gao H, et al. Injectable anti-inflammatory supramolecular nanofiber hydrogel to promote anti-VEGF therapy in age-related macular degeneration Treatment. Adv Mater. 2023;35(2): e2204994.","journal-title":"Adv Mater"},{"issue":"9","key":"3095_CR11","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.ophtha.2022.02.018","volume":"129","author":"M Court","year":"2022","unstructured":"Court M, Barry S, Elkeeb A. Retinal and choroidal vascular occlusion after intranasal triamcinolone injection. Ophthalmology. 2022;129(9):1055.","journal-title":"Ophthalmology"},{"issue":"1","key":"3095_CR12","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1038\/s41467-021-23232-7","volume":"12","author":"K Battiston","year":"2021","unstructured":"Battiston K, et al. Polymer-free corticosteroid dimer implants for controlled and sustained drug delivery. Nat Commun. 2021;12(1):2875.","journal-title":"Nat Commun"},{"key":"3095_CR13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.jconrel.2021.03.023","volume":"333","author":"S Wu","year":"2021","unstructured":"Wu S, et al. Controlled release of triamcinolone from an episcleral micro film delivery system for open-globe eye injuries and proliferative vitreoretinopathy. J Control Release. 2021;333:76\u201390.","journal-title":"J Control Release"},{"key":"3095_CR14","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202314095","author":"J Shen","year":"2024","unstructured":"Shen J, et al. Emerging co-assembled and sustained released natural medicinal nanoparticles for multi-target therapy of choroidal Neovascularization. Adv Mater. 2024. https:\/\/doi.org\/10.1002\/adma.202314095.","journal-title":"Adv Mater"},{"issue":"10326","key":"3095_CR15","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/S0140-6736(22)00010-1","volume":"399","author":"J Heier","year":"2022","unstructured":"Heier J, et al. Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials. Lancet. 2022;399(10326):729\u201340.","journal-title":"Lancet"},{"key":"3095_CR16","doi-asserted-by":"publisher","first-page":"1209527","DOI":"10.3389\/fnins.2023.1209527","volume":"17","author":"MI Avrutsky","year":"2023","unstructured":"Avrutsky MI, et al. Caspase-9 inhibition confers stronger neuronal and vascular protection compared to VEGF neutralization in a mouse model of retinal vein occlusion. Front Neurosci. 2023;17:1209527.","journal-title":"Front Neurosci"},{"issue":"15","key":"3095_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202003699","volume":"9","author":"Z Tang","year":"2022","unstructured":"Tang Z, et al. Ocular nanomedicine. Adv Sci. 2022;9(15): e2003699.","journal-title":"Adv Sci"},{"key":"3095_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25031727","author":"D Rodriguez","year":"2024","unstructured":"Rodriguez D, et al. Therapeutic delivery of doluble fractalkine ameliorates vascular dysfunction in the diabetic retina. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25031727.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3095_CR19","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.1038\/s41467-023-40655-6","volume":"14","author":"Y Wu","year":"2023","unstructured":"Wu Y, et al. AAV-mediated base-editing therapy ameliorates the disease phenotypes in a mouse model of retinitis pigmentosa. Nat Commun. 2023;14(1):4923.","journal-title":"Nat Commun"},{"issue":"9","key":"3095_CR20","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1016\/j.ymthe.2023.06.012","volume":"31","author":"M Toms","year":"2023","unstructured":"Toms M, et al. Successful large gene augmentation of USH2A with non-viral episomal vectors. Mol Ther. 2023;31(9):2755\u201366.","journal-title":"Mol Ther"},{"key":"3095_CR21","doi-asserted-by":"publisher","DOI":"10.1172\/JCI154619","author":"S Gasparini","year":"2022","unstructured":"Gasparini S, et al. Transplanted human cones incorporate into the retina and function in a murine cone degeneration model. J Clin Invest. 2022. https:\/\/doi.org\/10.1172\/JCI154619.","journal-title":"J Clin Invest"},{"key":"3095_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202202219","author":"L Zhou","year":"2022","unstructured":"Zhou L, et al. Highly efficient photodynamic therapy with mitochondria-targeting aggregation-induced emission photosensitizer for retinoblastoma. Adv Healthc Mater. 2022. https:\/\/doi.org\/10.1002\/adhm.202202219.","journal-title":"Adv Healthc Mater"},{"key":"3095_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ph15080985","author":"CD Thomas","year":"2022","unstructured":"Thomas CD, et al. Increased PDT efficacy when associated with nitroglycerin: A study on retinoblastoma xenografted on mice. Pharmaceuticals (Basel). 2022. https:\/\/doi.org\/10.3390\/ph15080985.","journal-title":"Pharmaceuticals (Basel)"},{"key":"3095_CR24","doi-asserted-by":"publisher","DOI":"10.3390\/polym14163265","author":"K Yao","year":"2022","unstructured":"Yao K, et al. Covalent organic framework (COF): a drug and carrier to attenuate retinal ganglion cells death in an acute glaucoma mouse model. Polymers. 2022. https:\/\/doi.org\/10.3390\/polym14163265.","journal-title":"Polymers"},{"issue":"18","key":"3095_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202000447","volume":"9","author":"G Choi","year":"2020","unstructured":"Choi G, et al. Antibacterial nanopillar array for an implantable intraocular lens. Adv Healthc Mater. 2020;9(18): e2000447.","journal-title":"Adv Healthc Mater"},{"issue":"6","key":"3095_CR26","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1038\/s41591-022-01862-8","volume":"28","author":"RN Van Gelder","year":"2022","unstructured":"Van Gelder RN, et al. Regenerative and restorative medicine for eye disease. Nat Med. 2022;28(6):1149\u201356.","journal-title":"Nat Med"},{"issue":"1","key":"3095_CR27","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.1038\/s41467-022-31180-z","volume":"13","author":"P Vagni","year":"2022","unstructured":"Vagni P, et al. POLYRETINA restores light responses in vivo in blind G\u00f6ttingen minipigs. Nat Commun. 2022;13(1):3678.","journal-title":"Nat Commun"},{"issue":"17","key":"3095_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202304626","volume":"13","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, et al. Recent advances in nanomedicine for ocular fundus neovascularization disease management. Adv Healthc Mater. 2024;13(17): e2304626.","journal-title":"Adv Healthc Mater"},{"key":"3095_CR29","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.jconrel.2024.01.063","volume":"367","author":"MB Appell","year":"2024","unstructured":"Appell MB, et al. Next generation therapeutics for retinal neurodegenerative diseases. J Control Release. 2024;367:708\u201336.","journal-title":"J Control Release"},{"issue":"3","key":"3095_CR30","doi-asserted-by":"publisher","first-page":"e681","DOI":"10.1111\/aos.14961","volume":"100","author":"F Lin","year":"2022","unstructured":"Lin F, et al. An investigation into the effects of ocular nebulization combined with meibomian gland massage on ocular surface status and corneal higher-order aberrations for the treatment of meibomian gland dysfunction. Acta Ophthalmol. 2022;100(3):e681\u201393.","journal-title":"Acta Ophthalmol"},{"key":"3095_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121948","volume":"293","author":"F Wong","year":"2023","unstructured":"Wong F, et al. Both non-coated and polyelectrolytically-coated intraocular collagen-alginate composite gels enhanced photoreceptor survival in retinal degeneration. Biomaterials. 2023;293: 121948.","journal-title":"Biomaterials"},{"issue":"1","key":"3095_CR32","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s41467-023-36205-9","volume":"14","author":"X Wu","year":"2023","unstructured":"Wu X, et al. Wearable in-sensor reservoir computing using optoelectronic polymers with through-space charge-transport characteristics for multi-task learning. Nat Commun. 2023;14(1):468.","journal-title":"Nat Commun"},{"issue":"1","key":"3095_CR33","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1021\/acsnano.2c05824","volume":"17","author":"DD Nguyen","year":"2023","unstructured":"Nguyen DD, et al. Highly retina-permeating and long-acting resveratrol\/metformin nanotherapeutics for enhanced treatment of macular degeneration. ACS Nano. 2023;17(1):168\u201383.","journal-title":"ACS Nano"},{"key":"3095_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14020384","author":"J Hanaguri","year":"2022","unstructured":"Hanaguri J, et al. Fenofibrate nano-eyedrops ameliorate retinal blood flow dysregulation and neurovascular coupling in Type 2 diabetic mice. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14020384.","journal-title":"Pharmaceutics"},{"key":"3095_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2021.117800","volume":"260","author":"C Xu","year":"2021","unstructured":"Xu C, et al. Multifunctional nanocomposite eye drops of cyclodextrin complex@layered double hydroxides for relay drug delivery to the posterior segment of the eye. Carbohydr Polym. 2021;260: 117800.","journal-title":"Carbohydr Polym"},{"issue":"7","key":"3095_CR36","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/aos.12803","volume":"93","author":"A Ohira","year":"2015","unstructured":"Ohira A, et al. Topical dexamethasone \u03b3-cyclodextrin nanoparticle eye drops increase visual acuity and decrease macular thickness in diabetic macular oedema. Acta Ophthalmol. 2015;93(7):610\u20135.","journal-title":"Acta Ophthalmol"},{"key":"3095_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2022.121755","volume":"621","author":"MY Badr","year":"2022","unstructured":"Badr MY, et al. The topical ocular delivery of rapamycin to posterior eye tissues and the suppression of retinal inflammatory disease. Int J Pharm. 2022;621: 121755.","journal-title":"Int J Pharm"},{"issue":"3","key":"3095_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202304053","volume":"11","author":"L Mu","year":"2024","unstructured":"Mu L, et al. Photothermal fibrous chitosan\/polydopamine sponge for intraoperative hemostasis and prevention of tumor recurrence in hepatocellular carcinomar resection. Adv Sci. 2024;11(3): e2304053.","journal-title":"Adv Sci"},{"key":"3095_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120900","volume":"606","author":"B Mahaling","year":"2021","unstructured":"Mahaling B, et al. A non-invasive nanoparticle-based sustained dual-drug delivery system as an eyedrop for endophthalmitis. Int J Pharm. 2021;606: 120900.","journal-title":"Int J Pharm"},{"key":"3095_CR40","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.ijbiomac.2021.03.017","volume":"180","author":"YH Cheng","year":"2021","unstructured":"Cheng YH, et al. Development of a dual delivery of levofloxacin and prednisolone acetate via PLGA nanoparticles\/ thermosensitive chitosan-based hydrogel for postoperative management: An in-vitro and ex-vivo study. Int J Biol Macromol. 2021;180:365\u201374.","journal-title":"Int J Biol Macromol"},{"key":"3095_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122429","volume":"305","author":"Y Jiang","year":"2024","unstructured":"Jiang Y, et al. Eyedrop delivery of therapeutic proteins with zwitterionic polymers to treat dry age-related macular degeneration. Biomaterials. 2024;305: 122429.","journal-title":"Biomaterials"},{"key":"3095_CR42","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abq3104","author":"J Shen","year":"2023","unstructured":"Shen J, et al. Eyedrop-based macromolecular ophthalmic drug delivery for ocular fundus disease treatment. Sci Adv. 2023. https:\/\/doi.org\/10.1126\/sciadv.abq3104.","journal-title":"Sci Adv"},{"key":"3095_CR43","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.actbio.2022.01.014","volume":"141","author":"L Sun","year":"2022","unstructured":"Sun L, et al. Rational design of mixed nanomicelle eye drops with structural integrity investigation. Acta Biomater. 2022;141:164\u201377.","journal-title":"Acta Biomater"},{"key":"3095_CR44","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.actbio.2020.01.008","volume":"104","author":"Y Wang","year":"2020","unstructured":"Wang Y, et al. Multifunctional carboxymethyl chitosan derivatives-layered double hydroxide hybrid nanocomposites for efficient drug delivery to the posterior segment of the eye. Acta Biomater. 2020;104:104\u201314.","journal-title":"Acta Biomater"},{"key":"3095_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15092273","author":"M Alkholief","year":"2023","unstructured":"Alkholief M, et al. Topical sustained-release dexamethasone-loaded chitosan nanoparticles: assessment of drug delivery efficiency in a rabbit model of endotoxin-induced uveitis. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15092273.","journal-title":"Pharmaceutics"},{"key":"3095_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2019.115356","volume":"227","author":"X Xu","year":"2020","unstructured":"Xu X, et al. Functional chitosan oligosaccharide nanomicelles for topical ocular drug delivery of dexamethasone. Carbohydr Polym. 2020;227: 115356.","journal-title":"Carbohydr Polym"},{"key":"3095_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14071479","author":"S Casey-Power","year":"2022","unstructured":"Casey-Power S, et al. Hyaluronic acid: its versatile use in ocular drug delivery with a specific focus on hyaluronic acid-based polyelectrolyte complexes. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14071479.","journal-title":"Pharmaceutics"},{"key":"3095_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202309920","author":"H Choi","year":"2024","unstructured":"Choi H, et al. Self-assembled oligopeptoplex-loaded dissolving icroneedles for adipocyte-targeted anti-obesity gene therapy. Adv Mater. 2024. https:\/\/doi.org\/10.1002\/adma.202309920.","journal-title":"Adv Mater"},{"key":"3095_CR49","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14061253","author":"CH Tsai","year":"2022","unstructured":"Tsai CH, et al. Valuation of topical and subconjunctival injection of hyaluronic acid-coated nanoparticles for drug delivery to posterior eye. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14061253.","journal-title":"Pharmaceutics"},{"key":"3095_CR50","doi-asserted-by":"publisher","first-page":"4481","DOI":"10.2147\/IJN.S316564","volume":"16","author":"SE Radwan","year":"2021","unstructured":"Radwan SE, et al. Hyaluronic-coated albumin anoparticles for the Nnon-invasive delivery of apatinib in iabetic retinopathy. Int J Nanomedicine. 2021;16:4481\u201394.","journal-title":"Int J Nanomedicine"},{"key":"3095_CR51","doi-asserted-by":"publisher","DOI":"10.3390\/cells9102171","author":"S Deguchi","year":"2020","unstructured":"Deguchi S, et al. In situ gel incorporating isulfiram nanoparticles rescues the detinal Dysfunction via ATP collapse in otsuka long-evans tokushima atty rats. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9102171.","journal-title":"Cells"},{"key":"3095_CR52","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13111781","author":"N Zoratto","year":"2021","unstructured":"Zoratto N, et al. Hyaluronan-holesterol nanogels for the enhancement of the ocular delivery of therapeutics. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13111781.","journal-title":"Pharmaceutics"},{"issue":"9","key":"3095_CR53","doi-asserted-by":"publisher","first-page":"6001","DOI":"10.1021\/acsabm.4c00585","volume":"7","author":"S Durak","year":"2024","unstructured":"Durak S, et al. A Nanogel formulation of anti-VEGF peptide for cular neovascularization treatment. ACS Appl Bio Mater. 2024;7(9):6001\u201313.","journal-title":"ACS Appl Bio Mater"},{"key":"3095_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2020.119020","volume":"576","author":"B Silva","year":"2020","unstructured":"Silva B, et al. New nanoparticles for topical ocular delivery of erythropoietin. Int J Pharm. 2020;576: 119020.","journal-title":"Int J Pharm"},{"key":"3095_CR55","doi-asserted-by":"publisher","DOI":"10.3390\/ph16020164","author":"B Silva","year":"2023","unstructured":"Silva B, et al. Topical administration of a anoformulation of hitosan-hyaluronic acid-epoetin beta in a rat model of glaucoma. Pharmaceuticals. 2023. https:\/\/doi.org\/10.3390\/ph16020164.","journal-title":"Pharmaceuticals"},{"key":"3095_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122459","volume":"305","author":"G Choi","year":"2024","unstructured":"Choi G, et al. Injectable alginate-based in situ self-healable transparent hydrogel as a vitreous substitute with a tamponading function. Biomaterials. 2024;305: 122459.","journal-title":"Biomaterials"},{"issue":"30","key":"3095_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302909","volume":"10","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, et al. Retinal microenvironment-protected rhein-GFFYE nanofibers attenuate retinal ischemia-reperfusion injury via inhibiting oxidative stress and regulating microglial\/macrophage M1\/M2 Polarization. Adv Sci. 2023;10(30): e2302909.","journal-title":"Adv Sci"},{"key":"3095_CR58","first-page":"2203351","volume":"3","author":"Y Li","year":"2022","unstructured":"Li Y, et al. Ophthalmic solution of smart supramolecular peptides to capture semaphorin 4D against diabetic retinopathy. Adv Sci. 2022;3:2203351.","journal-title":"Adv Sci"},{"key":"3095_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2021.121361","volume":"281","author":"K Li","year":"2022","unstructured":"Li K, et al. Glycopeptide-nanotransforrs eyedrops with enhanced permeability and retention for preventing fundus neovascularization. Biomaterials. 2022;281: 121361.","journal-title":"Biomaterials"},{"issue":"2","key":"3095_CR60","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202302765","volume":"20","author":"J Zhou","year":"2024","unstructured":"Zhou J, et al. Aflibercept loaded eye-drop hydrogel mediated with ell-penetrating peptide for corneal neovascularization treatment. Small. 2024;20(2): e2302765.","journal-title":"Small"},{"key":"3095_CR61","doi-asserted-by":"publisher","first-page":"35","DOI":"10.2147\/IJN.S428684","volume":"19","author":"W Hu","year":"2024","unstructured":"Hu W, et al. Topical application of cell-penetrating peptide modified anti-vegf drug alleviated choroidal neovascularization in mice. Int J Nanomedicine. 2024;19:35\u201351.","journal-title":"Int J Nanomedicine"},{"issue":"1","key":"3095_CR62","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/1061186X.2023.2295220","volume":"32","author":"D Zhu","year":"2024","unstructured":"Zhu D, et al. Enhanced neuroprotective activity of ophthalmic delivered nerve growth factor conjugated with cell penetrating peptide against optic nerve injury. J Drug Target. 2024;32(1):93\u20139.","journal-title":"J Drug Target"},{"key":"3095_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2022.05.009","author":"Y Huang","year":"2022","unstructured":"Huang Y, et al. Penetrating-peptide-mediated non-invasive Axitinib delivery for anti-neovascularisation. J Control Release. 2022. https:\/\/doi.org\/10.1016\/j.jconrel.2022.05.009.","journal-title":"J Control Release"},{"key":"3095_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2022.121493","volume":"284","author":"K Jiang","year":"2022","unstructured":"Jiang K, et al. Topical instillation of cell-penetrating peptide-conjugated melphalan blocks metastases of retinoblastoma. Biomaterials. 2022;284: 121493.","journal-title":"Biomaterials"},{"issue":"9","key":"3095_CR65","doi-asserted-by":"publisher","first-page":"2911","DOI":"10.1039\/D2CS00759B","volume":"52","author":"D Wu","year":"2023","unstructured":"Wu D, et al. Polymerization in living organisms. Chem Soc Rev. 2023;52(9):2911\u201345.","journal-title":"Chem Soc Rev"},{"issue":"1","key":"3095_CR66","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1038\/s41467-023-38056-w","volume":"14","author":"HT Hsueh","year":"2023","unstructured":"Hsueh HT, et al. Machine learning-driven multifunctional peptide engineering for sustained ocular drug delivery. Nat Commun. 2023;14(1):2509.","journal-title":"Nat Commun"},{"key":"3095_CR67","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jconrel.2023.08.058","volume":"362","author":"HT Hsueh","year":"2023","unstructured":"Hsueh HT, et al. Engineered peptide-drug conjugate provides sustained protection of retinal ganglion cells with topical administration in rats. J Control Release. 2023;362:371\u201380.","journal-title":"J Control Release"},{"issue":"4","key":"3095_CR68","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1038\/s41573-020-00135-8","volume":"20","author":"M Muttenthaler","year":"2021","unstructured":"Muttenthaler M, et al. Trends in peptide drug discovery. Nat Rev Drug Discov. 2021;20(4):309\u201325.","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"3095_CR69","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1038\/s41551-020-00606-8","volume":"4","author":"YC Kim","year":"2020","unstructured":"Kim YC, et al. Gelling hypotonic polymer solution for extended topical drug delivery to the eye. Nat Biomed Eng. 2020;4(11):1053\u201362.","journal-title":"Nat Biomed Eng"},{"key":"3095_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/polym13183038","author":"C Ponnusamy","year":"2021","unstructured":"Ponnusamy C, et al. Development and evaluation of polyvinylpyrrolidone k90 and poloxamer 407 self-assembled nanomicelles: enhanced topical ocular delivery of artemisinin. Polymers. 2021. https:\/\/doi.org\/10.3390\/polym13183038.","journal-title":"Polymers"},{"key":"3095_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2021.130498","author":"J Wang","year":"2021","unstructured":"Wang J, et al. Nano-in-nano dendrimer gel particles for efficient topical delivery of antiglaucoma drugs into the eye. Chem Eng J. 2021. https:\/\/doi.org\/10.1016\/j.cej.2021.130498.","journal-title":"Chem Eng J"},{"key":"3095_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121045","volume":"608","author":"DA Srinivasarao","year":"2021","unstructured":"Srinivasarao DA, et al. Simultaneous amelioration of diabetic ocular complications in lens and retinal tissues using a non-invasive drug delivery system. Int J Pharm. 2021;608: 121045.","journal-title":"Int J Pharm"},{"key":"3095_CR73","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adf4608","author":"T Meng","year":"2023","unstructured":"Meng T, et al. Six-month effective treatment of corneal graft rejection. Sci Adv. 2023. https:\/\/doi.org\/10.1126\/sciadv.adf4608.","journal-title":"Sci Adv"},{"issue":"5","key":"3095_CR74","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1016\/j.apsb.2021.10.022","volume":"12","author":"W Xia","year":"2022","unstructured":"Xia W, et al. Intravenous route to choroidal neovascularization by macrophage-disguised nanocarriers for mTOR modulation. Acta Pharm Sin B. 2022;12(5):2506\u201321.","journal-title":"Acta Pharm Sin B"},{"key":"3095_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.121379","volume":"612","author":"G Esteruelas","year":"2022","unstructured":"Esteruelas G, et al. Development and optimization of riluzole-loaded biodegradable nanoparticles incorporated in a mucoadhesive in situ gel for the posterior eye segment. Int J Pharm. 2022;612: 121379.","journal-title":"Int J Pharm"},{"key":"3095_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.123161","volume":"642","author":"NG Eissa","year":"2023","unstructured":"Eissa NG, et al. Morphologic design of nanogold carriers for a carbonic anhydrase inhibitor: effect on ocular retention and intraocular pressure. Int J Pharm. 2023;642: 123161.","journal-title":"Int J Pharm"},{"issue":"2","key":"3095_CR77","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1021\/acsabm.0c01334","volume":"4","author":"X He","year":"2021","unstructured":"He X, et al. Laser-activated drug implant for controlled release to the posterior segment of the eye. ACS Appl Bio Mater. 2021;4(2):1461\u20139.","journal-title":"ACS Appl Bio Mater"},{"issue":"2","key":"3095_CR78","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s40265-019-01248-0","volume":"80","author":"ER Craven","year":"2020","unstructured":"Craven ER, et al. 24-month phase i\/ii clinical trial of bimatoprost sustained-release implant (bimatoprost sr) in glaucoma patients. Drugs. 2020;80(2):167\u201379.","journal-title":"Drugs"},{"issue":"12","key":"3095_CR79","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1016\/j.ophtha.2020.06.018","volume":"127","author":"FA Medeiros","year":"2020","unstructured":"Medeiros FA, et al. Phase 3, Randomized, 20-month study of bimatoprost implant in open-angle glaucoma and ocular hypertension (ARTEMIS 1). Ophthalmology. 2020;127(12):1627\u201341.","journal-title":"Ophthalmology"},{"issue":"10","key":"3095_CR80","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202105373","volume":"9","author":"R De","year":"2022","unstructured":"De R, Mahata MK, Kim KT. Structure-based varieties of polymeric nanocarriers and influences of their physicochemical properties on drug delivery profiles. Adv Sci. 2022;9(10): e2105373.","journal-title":"Adv Sci"},{"issue":"4","key":"3095_CR81","doi-asserted-by":"publisher","DOI":"10.1002\/smtd.202200014","volume":"6","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, et al. confinement assembly in polymeric micelles enables nanoparticle superstructures with tunable molecular-like geometries. Small Methods. 2022;6(4): e2200014.","journal-title":"Small Methods"},{"issue":"1","key":"3095_CR82","doi-asserted-by":"publisher","DOI":"10.1002\/biot.202300462","volume":"19","author":"N Sharifi","year":"2024","unstructured":"Sharifi N, et al. Developing nanosize carrier systems for Amphotericin-B: a review on the biomedical application of nanoparticles for the treatment of leishmaniasis and fungal infections. Biotechnol J. 2024;19(1): e2300462.","journal-title":"Biotechnol J"},{"issue":"6","key":"3095_CR83","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1021\/acs.molpharmaceut.7b00128","volume":"14","author":"A Mandal","year":"2017","unstructured":"Mandal A, et al. Topical formulation of self-assembled antiviral prodrug nanomicelles for targeted retinal delivery. Mol Pharm. 2017;14(6):2056\u201369.","journal-title":"Mol Pharm"},{"issue":"25","key":"3095_CR84","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202108360","volume":"34","author":"X Zhao","year":"2022","unstructured":"Zhao X, et al. Antiangiogenic nanomicelles for the topical delivery of aflibercept to treat retinal neovascular disease. Adv Mater. 2022;34(25): e2108360.","journal-title":"Adv Mater"},{"issue":"1","key":"3095_CR85","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12951-023-01829-y","volume":"21","author":"W Su","year":"2023","unstructured":"Su W, et al. An intravitreal-injectable hydrogel depot doped borneol-decorated dual-drug-coloaded microemulsions for long-lasting retina delivery and synergistic therapy of wAMD. J Nanobiotechnology. 2023;21(1):71.","journal-title":"J Nanobiotechnology"},{"issue":"14","key":"3095_CR86","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202303659","volume":"13","author":"C Liu","year":"2024","unstructured":"Liu C, et al. A sustainable retinal drug co-delivery for boosting therapeutic efficacy in wAMD: unveiling multifaceted evidence and synergistic mechanisms. Adv Healthc Mater. 2024;13(14): e2303659.","journal-title":"Adv Healthc Mater"},{"issue":"1","key":"3095_CR87","doi-asserted-by":"publisher","first-page":"20554","DOI":"10.1038\/s41598-020-77254-0","volume":"10","author":"S Delgado-Tirado","year":"2020","unstructured":"Delgado-Tirado S, et al. Topical delivery of a small molecule RUNX1 transcription factor inhibitor for the treatment of proliferative vitreoretinopathy. Sci Rep. 2020;10(1):20554.","journal-title":"Sci Rep"},{"issue":"8","key":"3095_CR88","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1089\/jop.2024.0055","volume":"40","author":"R Kashikar","year":"2024","unstructured":"Kashikar R, et al. Ophthalmic nanoemulsion fingolimod formulation for topical application. J Ocul Pharmacol Ther. 2024;40(8):504\u201312.","journal-title":"J Ocul Pharmacol Ther"},{"key":"3095_CR89","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/biology10121328","volume":"10","author":"L Huang","year":"2021","unstructured":"Huang L, et al. Therapeutic effects of fenofibrate nano-emulsion eye drops on retinal vascular leakage and neovascularization. Biology. 2021;10:12.","journal-title":"Biology"},{"key":"3095_CR90","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.jconrel.2023.08.004","volume":"361","author":"X Guo","year":"2023","unstructured":"Guo X, et al. Antioxidant nanoemulsion loaded with latanoprost enables highly effective glaucoma treatment. J Control Release. 2023;361:534\u201346.","journal-title":"J Control Release"},{"key":"3095_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2024.123840","volume":"653","author":"M Dehghani","year":"2024","unstructured":"Dehghani M, et al. Triamcinolone-loaded self nano-emulsifying drug delivery systems for ocular use: an alternative to invasive ocular surgeries and injections. Int J Pharm. 2024;653: 123840.","journal-title":"Int J Pharm"},{"issue":"6","key":"3095_CR92","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2022.101736","volume":"45","author":"M Markoulli","year":"2022","unstructured":"Markoulli M, et al. The effect of hydroxypropyl-guar nanoemulsion on signs and symptoms of dry eye. Cont Lens Anterior Eye. 2022;45(6): 101736.","journal-title":"Cont Lens Anterior Eye"},{"issue":"2","key":"3095_CR93","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1089\/jop.2020.0085","volume":"37","author":"GW Oliverio","year":"2021","unstructured":"Oliverio GW, et al. Safety and tolerability of an eye drop based on 0.6% povidone-iodine nanoemulsion in dry eye patients. J Ocul Pharmacol Ther. 2021;37(2):90\u20136.","journal-title":"J Ocul Pharmacol Ther"},{"key":"3095_CR94","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26154673","author":"C Puglia","year":"2021","unstructured":"Puglia C, et al. Lipid nanoparticles traverse non-corneal path to reach the posterior eye segment: in vivo evidence. Molecules. 2021. https:\/\/doi.org\/10.3390\/molecules26154673.","journal-title":"Molecules"},{"key":"3095_CR95","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2021.120405","volume":"598","author":"B Wu","year":"2021","unstructured":"Wu B, et al. Cell penetrating peptide TAT-functionalized liposomes for efficient ophthalmic delivery of flurbiprofen: penetration and its underlying mechanism, retention, anti-inflammation and biocompatibility. Int J Pharm. 2021;598: 120405.","journal-title":"Int J Pharm"},{"key":"3095_CR96","first-page":"2855","volume":"15","author":"CZ Chambers","year":"2023","unstructured":"Chambers CZ, et al. Lipid nanoparticle-mediated delivery of mRNA into the mouse and human retina and other ocular tissues. bioRxiv. 2023;15:2855.","journal-title":"bioRxiv"},{"key":"3095_CR97","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abo6638","author":"M Bohley","year":"2022","unstructured":"Bohley M, et al. A single intravenous injection of cyclosporin a-loaded lipid nanocapsules prevents retinopathy of prematurity. Sci Adv. 2022. https:\/\/doi.org\/10.1126\/sciadv.abo6638.","journal-title":"Sci Adv"},{"key":"3095_CR98","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2023.120960","volume":"315","author":"J Lu","year":"2023","unstructured":"Lu J, et al. In vitro and in vivo assessment of structural integrity for HPCD complex@Liposome nanocomposites from ocular surface to the posterior segment of the eye. Carbohydr Polym. 2023;315: 120960.","journal-title":"Carbohydr Polym"},{"key":"3095_CR99","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2023.122987","volume":"641","author":"Z Li","year":"2023","unstructured":"Li Z, et al. Efficiency co-delivery of ellagic acid and oxygen by a non-invasive liposome for ameliorating diabetic retinopathy. Int J Pharm. 2023;641: 122987.","journal-title":"Int J Pharm"},{"key":"3095_CR100","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.2147\/IJN.S446425","volume":"19","author":"C Sun","year":"2024","unstructured":"Sun C, et al. Topical ophthalmic liposomes dual-modified with penetratin and hyaluronic acid for the noninvasive treatment of neovascular age-related macular degeneration. Int J Nanomedicine. 2024;19:1887\u2013908.","journal-title":"Int J Nanomedicine"},{"key":"3095_CR101","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15020611","author":"S Nishida","year":"2023","unstructured":"Nishida S, et al. A multifunctional hybrid nanocarrier for non-invasive siRNA delivery to the retina. Pharmaceutics. 2023. https:\/\/doi.org\/10.3390\/pharmaceutics15020611.","journal-title":"Pharmaceutics"},{"key":"3095_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13040523","author":"AB Nair","year":"2021","unstructured":"Nair AB, et al. Clarithromycin solid lipid nanoparticles for topical ocular therapy: optimization, evaluation and in vivo studies. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13040523.","journal-title":"Pharmaceutics"},{"issue":"6","key":"3095_CR103","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1080\/1061186X.2020.1871483","volume":"29","author":"S Kakkar","year":"2021","unstructured":"Kakkar S, et al. Lipo-PEG nano-ocular formulation successfully encapsulates hydrophilic fluconazole and traverses corneal and non-corneal path to reach posterior eye segment. J Drug Target. 2021;29(6):631\u201350.","journal-title":"J Drug Target"},{"issue":"1","key":"3095_CR104","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1080\/10717544.2021.1902023","volume":"28","author":"E Abd-Elhakeem","year":"2021","unstructured":"Abd-Elhakeem E, El-Nabarawi M, Shamma R. Lipid-based nano-formulation platform for eplerenone oral delivery as a potential treatment of chronic central serous chorioretinopathy: in-vitro optimization and ex-vivo assessment. Drug Deliv. 2021;28(1):642\u201354.","journal-title":"Drug Deliv"},{"key":"3095_CR105","doi-asserted-by":"publisher","DOI":"10.3390\/nano10020287","author":"C Puglia","year":"2020","unstructured":"Puglia C, et al. Ocular formulation based on palmitoylethanolamide-loaded nanostructured lipid carriers: technological and pharmacological profile. Nanomaterials. 2020. https:\/\/doi.org\/10.3390\/nano10020287.","journal-title":"Nanomaterials"},{"key":"3095_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2021.105991","volume":"167","author":"K Jounaki","year":"2021","unstructured":"Jounaki K, et al. Topical ocular delivery of vancomycin loaded cationic lipid nanocarriers as a promising and non-invasive alternative approach to intravitreal injection for enhanced bacterial endophthalmitis management. Eur J Pharm Sci. 2021;167: 105991.","journal-title":"Eur J Pharm Sci"},{"key":"3095_CR107","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13030322","author":"J Navarro-Partida","year":"2021","unstructured":"Navarro-Partida J, et al. Safety and tolerability of topical ophthalmic triamcinolone acetonide-loaded liposomes formulation and evaluation of its biologic activity in patients with diabetic macular edema. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13030322.","journal-title":"Pharmaceutics"},{"key":"3095_CR108","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13091491","author":"J Navarro-Partida","year":"2021","unstructured":"Navarro-Partida J, et al. Topical triamcinolone acetonide-loaded liposome formulation used as an adjuvant to intravitreal ranibizumab therapy for neovascular age-related macular degeneration. Pharmaceutics. 2021. https:\/\/doi.org\/10.3390\/pharmaceutics13091491.","journal-title":"Pharmaceutics"},{"key":"3095_CR109","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2023.100602","volume":"19","author":"X Gui","year":"2023","unstructured":"Gui X, et al. Exosomes incorporated with black phosphorus quantum dots attenuate retinal angiogenesis via disrupting glucose metabolism. Mater Today Bio. 2023;19: 100602.","journal-title":"Mater Today Bio"},{"issue":"26","key":"3095_CR110","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302174","volume":"10","author":"CJ Yang","year":"2023","unstructured":"Yang CJ, Nguyen DD, Lai JY. Poly(l-histidine)-mediated on-demand therapeutic delivery of roughened ceria nanocages for treatment of chemical eye injury. Adv Sci. 2023;10(26): e2302174.","journal-title":"Adv Sci"},{"issue":"40","key":"3095_CR111","doi-asserted-by":"publisher","DOI":"10.1002\/smll.201902776","volume":"15","author":"A Shoval","year":"2019","unstructured":"Shoval A, et al. Anti-VEGF-aptamer modified c-dots-a hybrid nanocomposite for topical treatment of ocular vascular disorders. Small. 2019;15(40): e1902776.","journal-title":"Small"},{"issue":"39","key":"3095_CR112","doi-asserted-by":"publisher","first-page":"2207335","DOI":"10.1002\/smll.202207335","volume":"19","author":"K Huang","year":"2023","unstructured":"Huang K, et al. MMP9-responsive graphene oxide quantum dot-based nano-in-micro drug delivery system for combinatorial therapy of choroidal neovascularization. Small. 2023;19(39):2207335.","journal-title":"Small"},{"key":"3095_CR113","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3390\/pharmaceutics13101650","volume":"13","author":"M Bassetto","year":"2021","unstructured":"Bassetto M, et al. Magnetically assisted drug delivery of topical eye drops maintains retinal function in vivo in mice. Pharmaceutics. 2021;13:10.","journal-title":"Pharmaceutics"},{"key":"3095_CR114","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.119961","volume":"243","author":"LJ Luo","year":"2020","unstructured":"Luo LJ, Nguyen DD, Lai JY. Dually functional hollow ceria nanoparticle platform for intraocular drug delivery: A push beyond the limits of static and dynamic ocular barriers toward glaucoma therapy. Biomaterials. 2020;243: 119961.","journal-title":"Biomaterials"},{"issue":"11","key":"3095_CR115","doi-asserted-by":"publisher","first-page":"5447","DOI":"10.7150\/thno.54525","volume":"11","author":"LJ Luo","year":"2021","unstructured":"Luo LJ, Nguyen DD, Lai JY. Harnessing the tunable cavity of nanoceria for enhancing Y-27632-mediated alleviation of ocular hypertension. Theranostics. 2021;11(11):5447\u201363.","journal-title":"Theranostics"},{"key":"3095_CR116","doi-asserted-by":"publisher","DOI":"10.3390\/polym13193324","author":"A Laradji","year":"2021","unstructured":"Laradji A, et al. Hyaluronic acid-based gold nanoparticles for the topical delivery of therapeutics to the retina and the retinal pigment epithelium. Polymers. 2021. https:\/\/doi.org\/10.3390\/polym13193324.","journal-title":"Polymers"},{"issue":"1","key":"3095_CR117","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1021\/acsbiomaterials.1c01234","volume":"8","author":"SV Mudigunda","year":"2022","unstructured":"Mudigunda SV, et al. Multifunctional polymeric nanoparticles for chemo\/phototheranostics of retinoblastoma. ACS Biomater Sci Eng. 2022;8(1):151\u201360.","journal-title":"ACS Biomater Sci Eng"},{"issue":"1","key":"3095_CR118","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/10717544.2022.2032876","volume":"29","author":"M Li","year":"2022","unstructured":"Li M, et al. Multifunctional liposome for photoacoustic\/ultrasound imaging-guided chemo\/photothermal retinoblastoma therapy. Drug Deliv. 2022;29(1):519\u201333.","journal-title":"Drug Deliv"},{"issue":"6","key":"3095_CR119","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.1016\/j.apsb.2021.10.009","volume":"12","author":"Y Liu","year":"2022","unstructured":"Liu Y, et al. Liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma. Acta Pharm Sin B. 2022;12(6):2731\u20139.","journal-title":"Acta Pharm Sin B"},{"issue":"49","key":"3095_CR120","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202305026","volume":"19","author":"A Coro","year":"2023","unstructured":"Coro A, et al. Ag(2) S biocompatible ensembles as dual OCT contrast agents and NIR ocular imaging probes. Small. 2023;19(49): e2305026.","journal-title":"Small"},{"issue":"46","key":"3095_CR121","doi-asserted-by":"publisher","first-page":"29065","DOI":"10.1039\/D1RA04431A","volume":"11","author":"Y Yu","year":"2021","unstructured":"Yu Y, et al. NIR-triggered upconversion nanoparticles@thermo-sensitive liposome hybrid theranostic nanoplatform for controlled drug delivery. RSC Adv. 2021;11(46):29065\u201372.","journal-title":"RSC Adv"},{"issue":"31","key":"3095_CR122","doi-asserted-by":"publisher","first-page":"10841","DOI":"10.1021\/acs.analchem.1c01108","volume":"93","author":"X Ren","year":"2021","unstructured":"Ren X, et al. Dopamine imaging in living cells and retina by surface-enhanced raman scattering based on functionalized gold nanoparticles. Anal Chem. 2021;93(31):10841\u20139.","journal-title":"Anal Chem"},{"issue":"14","key":"3095_CR123","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.2217\/nnm-2018-0299","volume":"14","author":"Y Chemla","year":"2019","unstructured":"Chemla Y, et al. Gold nanoparticles for multimodal high-resolution imaging of transplanted cells for retinal replacement therapy. Nanomedicine. 2019;14(14):1857\u201371.","journal-title":"Nanomedicine"},{"issue":"10","key":"3095_CR124","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1021\/acssensors.0c00908","volume":"5","author":"VP Nguyen","year":"2020","unstructured":"Nguyen VP, et al. Plasmonic gold nanostar-enhanced multimodal photoacoustic microscopy and optical coherence tomography molecular imaging to evaluate choroidal neovascularization. ACS Sens. 2020;5(10):3070\u201381.","journal-title":"ACS Sens"},{"key":"3095_CR125","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/bs.mie.2021.06.038","volume":"657","author":"VP Nguyen","year":"2021","unstructured":"Nguyen VP, et al. Functionalized contrast agents for multimodality photoacoustic microscopy, optical coherence tomography, and fluorescence microscopy molecular retinal imaging. Meth Enzymol. 2021;657:443\u201380.","journal-title":"Meth Enzymol"},{"issue":"1","key":"3095_CR126","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41467-020-20276-z","volume":"12","author":"VP Nguyen","year":"2021","unstructured":"Nguyen VP, et al. Chain-like gold nanoparticle clusters for multimodal photoacoustic microscopy and optical coherence tomography enhanced molecular imaging. Nat Commun. 2021;12(1):34.","journal-title":"Nat Commun"},{"issue":"31","key":"3095_CR127","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202302069","volume":"35","author":"VP Nguyen","year":"2023","unstructured":"Nguyen VP, et al. Renally clearable ultraminiature chain-like gold nanoparticle clusters for multimodal molecular imaging of choroidal neovascularization. Adv Mater. 2023;35(31): e2302069.","journal-title":"Adv Mater"},{"key":"3095_CR128","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.1c03035","author":"VP Nguyen","year":"2021","unstructured":"Nguyen VP, et al. Long-term, noninvasive in vivo tracking of progenitor cells using multimodality photoacoustic, optical coherence tomography, and fluorescence imaging. ACS Nano. 2021. https:\/\/doi.org\/10.1021\/acsnano.1c03035.","journal-title":"ACS Nano"},{"issue":"34","key":"3095_CR129","doi-asserted-by":"publisher","first-page":"40214","DOI":"10.1021\/acsami.1c03504","volume":"13","author":"VP Nguyen","year":"2021","unstructured":"Nguyen VP, et al. Gold nanorod enhanced photoacoustic microscopy and optical coherence tomography of choroidal neovascularization. ACS Appl Mater Interfaces. 2021;13(34):40214\u201328.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"19","key":"3095_CR130","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202110690","volume":"34","author":"J Zhang","year":"2022","unstructured":"Zhang J, et al. A multifunctional photoacoustic\/fluorescence dual-mode-imaging gold-based theranostic nanoformulation without external laser limitations. Adv Mater. 2022;34(19): e2110690.","journal-title":"Adv Mater"},{"issue":"20","key":"3095_CR131","doi-asserted-by":"publisher","first-page":"8595","DOI":"10.1021\/acs.nanolett.1c02291","volume":"21","author":"P Keahey","year":"2021","unstructured":"Keahey P, et al. Spectral- and polarization-dependent scattering of gold nanobipyramids for exogenous contrast in optical coherence tomography. Nano Lett. 2021;21(20):8595\u2013601.","journal-title":"Nano Lett"},{"issue":"9","key":"3095_CR132","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1089\/ten.tec.2019.0136","volume":"25","author":"DJ Ma","year":"2019","unstructured":"Ma DJ, et al. Magnetic iron oxide nanoparticle labeling of photoreceptor precursors for magnetic resonance imaging. Tissue Eng Part C Methods. 2019;25(9):532\u201342.","journal-title":"Tissue Eng Part C Methods"},{"issue":"41","key":"3095_CR133","doi-asserted-by":"publisher","first-page":"14099","DOI":"10.1021\/acs.analchem.1c05378","volume":"94","author":"Y Pan","year":"2022","unstructured":"Pan Y, et al. Highly selective purification of plasma extracellular vesicles using titanium dioxide microparticles for depicting the metabolic signatures of diabetic retinopathy. Anal Chem. 2022;94(41):14099\u2013108.","journal-title":"Anal Chem"},{"issue":"10","key":"3095_CR134","doi-asserted-by":"publisher","first-page":"7644","DOI":"10.1021\/acsnano.4c00699","volume":"18","author":"H Zhang","year":"2024","unstructured":"Zhang H, et al. Iron oxide nanoparticles engineered macrophage-derived exosomes for targeted pathological angiogenesis therapy. ACS Nano. 2024;18(10):7644\u201355.","journal-title":"ACS Nano"},{"issue":"11","key":"3095_CR135","doi-asserted-by":"publisher","first-page":"15403","DOI":"10.1021\/acsnano.0c06000","volume":"14","author":"L Li","year":"2020","unstructured":"Li L, et al. Microenvironment-triggered degradable hydrogel for imaging diagnosis and combined treatment of intraocular choroidal melanoma. ACS Nano. 2020;14(11):15403\u201316.","journal-title":"ACS Nano"},{"issue":"7","key":"3095_CR136","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202205754","volume":"19","author":"VB Kumar","year":"2023","unstructured":"Kumar VB, et al. Functional carbon quantum dots for ocular imaging and therapeutic applications. Small. 2023;19(7): e2205754.","journal-title":"Small"},{"issue":"9","key":"3095_CR137","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202103254","volume":"9","author":"GH Lee","year":"2022","unstructured":"Lee GH, et al. Smart wireless near-infrared light emitting contact lens for the treatment of diabetic retinopathy. Adv Sci. 2022;9(9): e2103254.","journal-title":"Adv Sci"},{"issue":"3","key":"3095_CR138","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1021\/acsbiomaterials.3c01972","volume":"10","author":"X Hu","year":"2024","unstructured":"Hu X, et al. Construction of a functional nucleic acid-based artificial vesicle-encapsulated composite nanoparticle and its application in retinoblastoma-targeted theranostics. ACS Biomater Sci Eng. 2024;10(3):1830\u201342.","journal-title":"ACS Biomater Sci Eng"},{"issue":"5","key":"3095_CR139","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1167\/tvst.8.5.18","volume":"8","author":"H Demirci","year":"2019","unstructured":"Demirci H, et al. Magnetic hyperthermia in Y79 retinoblastoma and ARPE-19 retinal epithelial cells: tumor selective apoptotic activity of iron oxide nanoparticle. Transl Vis Sci Technol. 2019;8(5):18.","journal-title":"Transl Vis Sci Technol"},{"issue":"1","key":"3095_CR140","doi-asserted-by":"publisher","first-page":"22358","DOI":"10.1038\/s41598-023-49171-5","volume":"13","author":"E Sadri","year":"2023","unstructured":"Sadri E, et al. Enhanced anti-tumor activity of transferrin\/folate dual-targeting magnetic nanoparticles using chemo-thermo therapy on retinoblastoma cancer cells Y79. Sci Rep. 2023;13(1):22358.","journal-title":"Sci Rep"},{"issue":"31","key":"3095_CR141","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202301985","volume":"10","author":"S Xu","year":"2023","unstructured":"Xu S, et al. Red light-triggered anti-angiogenic and photodynamic combination therapy of age-related macular degeneration. Adv Sci. 2023;10(31): e2301985.","journal-title":"Adv Sci"},{"issue":"20","key":"3095_CR142","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202101754","volume":"8","author":"K Long","year":"2021","unstructured":"Long K, et al. Green light-triggered intraocular drug release for intravenous chemotherapy of retinoblastoma. Adv Sci. 2021;8(20): e2101754.","journal-title":"Adv Sci"},{"issue":"41","key":"3095_CR143","doi-asserted-by":"publisher","first-page":"48027","DOI":"10.1021\/acsami.3c11053","volume":"15","author":"Y Li","year":"2023","unstructured":"Li Y, et al. Near-infrared BODIPY photosensitizer for modulating mitochondrial fusion proteins and inhibiting choroidal neovascularization. ACS Appl Mater Interfaces. 2023;15(41):48027\u201337.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3095_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122458","volume":"305","author":"Q Wang","year":"2024","unstructured":"Wang Q, et al. Ultrasound-enhanced nano catalyst with ferroptosis-apoptosis combined anticancer strategy for metastatic uveal melanoma. Biomaterials. 2024;305: 122458.","journal-title":"Biomaterials"},{"issue":"5","key":"3095_CR145","doi-asserted-by":"publisher","first-page":"5642","DOI":"10.1021\/acsami.9b22072","volume":"12","author":"M Wang","year":"2020","unstructured":"Wang M, et al. Multifunctional nanoparticles for multimodal imaging-guided low-intensity focused ultrasound\/immunosynergistic retinoblastoma therapy. ACS Appl Mater Interfaces. 2020;12(5):5642\u201357.","journal-title":"ACS Appl Mater Interfaces"},{"key":"3095_CR146","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.2147\/IJN.S364264","volume":"17","author":"W Zheng","year":"2022","unstructured":"Zheng W, et al. Dual-target multifunctional superparamagnetic cationic nanoliposomes for multimodal imaging-guided synergistic photothermal\/photodynamic therapy of retinoblastoma. Int J Nanomed. 2022;17:3217\u201337.","journal-title":"Int J Nanomed"},{"key":"3095_CR147","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.actbio.2023.07.022","volume":"168","author":"D Wu","year":"2023","unstructured":"Wu D, et al. Dynamically assembled nanomedicine based on host-guest molecular recognition for NIR laser-excited chemotherapy and phototheranostics. Acta Biomater. 2023;168:565\u201379.","journal-title":"Acta Biomater"},{"issue":"1","key":"3095_CR148","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s10020-024-00785-z","volume":"30","author":"T Niu","year":"2024","unstructured":"Niu T, et al. Porous Se@SiO(2) nanospheres alleviate diabetic retinopathy by inhibiting excess lipid peroxidation and inflammation. Mol Med. 2024;30(1):24.","journal-title":"Mol Med"},{"issue":"35","key":"3095_CR149","doi-asserted-by":"publisher","first-page":"2002791","DOI":"10.1002\/adfm.202002791","volume":"30","author":"V Vedarethinam","year":"2020","unstructured":"Vedarethinam V, et al. vanadium core\u2013shell nanorods inspect metabolic changes of diabetic retinopathy. Adv Funct Mater. 2020;30(35):2002791.","journal-title":"Adv Funct Mater"},{"key":"3095_CR150","doi-asserted-by":"publisher","first-page":"e2303713","DOI":"10.1002\/adhm.202303713","volume":"11","author":"J Ki","year":"2024","unstructured":"Ki J, et al. Visualization materials using silicon-based optical nanodisks (ViSiON) for enhanced NIR imaging in ophthalmology. Adv Healthc Mater. 2024;11:e2303713.","journal-title":"Adv Healthc Mater"},{"issue":"2","key":"3095_CR151","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1021\/acs.biomac.2c01469","volume":"24","author":"D Wu","year":"2023","unstructured":"Wu D, et al. Supramolecular theranostic nanomedicine for in situ self-boosting cancer photochemotherapy. Biomacromol. 2023;24(2):1022\u201331.","journal-title":"Biomacromol"},{"key":"3095_CR152","doi-asserted-by":"publisher","DOI":"10.1002\/adtp.202000181","author":"H Cho","year":"2021","unstructured":"Cho H, et al. Dendrimer-triamcinolone acetonide reduces neuroinflammation, pathological angiogenesis, and neuroretinal dysfunction in ischemic retinopathy. Adv Ther. 2021. https:\/\/doi.org\/10.1002\/adtp.202000181.","journal-title":"Adv Ther"},{"key":"3095_CR153","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102460","volume":"56","author":"K Liu","year":"2022","unstructured":"Liu K, et al. Capsaicin ameliorates diabetic retinopathy by inhibiting poldip2-induced oxidative stress. Redox Biol. 2022;56: 102460.","journal-title":"Redox Biol"},{"key":"3095_CR154","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.jconrel.2022.08.026","volume":"350","author":"B Xue","year":"2022","unstructured":"Xue B, et al. Mitochondria-targeted nanozymes eliminate oxidative damage in retinal neovascularization disease. J Control Release. 2022;350:271\u201383.","journal-title":"J Control Release"},{"issue":"11","key":"3095_CR155","doi-asserted-by":"publisher","first-page":"6981","DOI":"10.1021\/acs.nanolett.8b02896","volume":"18","author":"AM Wilson","year":"2018","unstructured":"Wilson AM, et al. In vivo laser-mediated retinal ganglion cell optoporation using K(V)11 conjugated gold nanoparticles. Nano Lett. 2018;18(11):6981\u20138.","journal-title":"Nano Lett"},{"key":"3095_CR156","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2020.102205","volume":"28","author":"R Singh","year":"2020","unstructured":"Singh R, et al. Inhibition of choroidal neovascularization by systemic delivery of gold nanoparticles. Nanomedicine. 2020;28: 102205.","journal-title":"Nanomedicine"},{"issue":"12","key":"3095_CR157","doi-asserted-by":"publisher","first-page":"5816","DOI":"10.1021\/acsabm.2c00809","volume":"5","author":"CS Shin","year":"2022","unstructured":"Shin CS, et al. Noninvasive delivery of self-regenerating cerium oxide nanoparticles to modulate oxidative stress in the retina. ACS Appl Bio Mater. 2022;5(12):5816\u201325.","journal-title":"ACS Appl Bio Mater"},{"issue":"1","key":"3095_CR158","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s12951-022-01362-4","volume":"20","author":"N Zhao","year":"2022","unstructured":"Zhao N, et al. Graphene quantum dots rescue angiogenic retinopathy via blocking STAT3\/Periostin\/ERK signaling. J Nanobiotechnology. 2022;20(1):174.","journal-title":"J Nanobiotechnology"},{"key":"3095_CR159","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.2147\/IJN.S440025","volume":"19","author":"Q Wang","year":"2024","unstructured":"Wang Q, et al. Chitosan-rapamycin carbon dots alleviate glaucomatous retinal injury by inducing autophagy to promote M2 microglial polarization. Int J Nanomedicine. 2024;19:2265\u201384.","journal-title":"Int J Nanomedicine"},{"issue":"8","key":"3095_CR160","volume":"12","author":"J Kieffer","year":"2020","unstructured":"Kieffer J, et al. Ceria nanoparticles mitigate the iron oxidative toxicity of human retinal pigment epithelium. Cureus. 2020;12(8): e9675.","journal-title":"Cureus"},{"key":"3095_CR161","doi-asserted-by":"publisher","DOI":"10.3390\/cells9071617","author":"A Tisi","year":"2020","unstructured":"Tisi A, et al. Nanoceria particles are an eligible candidate to prevent age-related macular degeneration by inhibiting retinal pigment epithelium cell death and autophagy alterations. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9071617.","journal-title":"Cells"},{"issue":"12","key":"3095_CR162","doi-asserted-by":"publisher","DOI":"10.1002\/smtd.202100848","volume":"5","author":"Z Tang","year":"2021","unstructured":"Tang Z, et al. Nanoprotection against retinal pigment epithelium degeneration via ferroptosis inhibition. Small Methods. 2021;5(12): e2100848.","journal-title":"Small Methods"},{"key":"3095_CR163","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.3c10982","author":"J Liao","year":"2024","unstructured":"Liao J, et al. Bioactive ceria nanoenzymes target mitochondria in reperfusion injury to treat ischemic stroke. ACS Nano. 2024. https:\/\/doi.org\/10.1021\/acsnano.3c10982.","journal-title":"ACS Nano"},{"issue":"36","key":"3095_CR164","doi-asserted-by":"publisher","first-page":"2370213","DOI":"10.1002\/adfm.202370213","volume":"33","author":"S Gui","year":"2023","unstructured":"Gui S, et al. Ultrasmall coordination polymer nanodots fe-quer nanozymes for preventing and delaying the development and progression of diabetic retinopathy. Adv Funct Mater. 2023;33(36):2370213.","journal-title":"Adv Funct Mater"},{"issue":"44","key":"3095_CR165","doi-asserted-by":"publisher","first-page":"2302493","DOI":"10.1002\/adfm.202302493","volume":"33","author":"L Zhou","year":"2023","unstructured":"Zhou L, et al. A novel photosynthetic biohybrid system for microenvironment regulation of diabetes retinopathy through continuous oxygen supply and nanozyme cascade reaction. Adv Funct Mater. 2023;33(44):2302493.","journal-title":"Adv Funct Mater"},{"issue":"39","key":"3095_CR166","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202205324","volume":"34","author":"R Zhang","year":"2022","unstructured":"Zhang R, et al. Edge-site engineering of defective Fe-N nanozymes with boosted catalase-like performance for retinal vasculopathies. Adv Mater. 2022;34(39): e2205324.","journal-title":"Adv Mater"},{"key":"3095_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103055","volume":"70","author":"H Zhao","year":"2024","unstructured":"Zhao H, et al. Twin defect-rich Pt ultrathin nanowire nanozymes alleviate inflammatory skin diseases by scavenging reactive oxygen species. Redox Biol. 2024;70: 103055.","journal-title":"Redox Biol"},{"issue":"10","key":"3095_CR168","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202209690","volume":"35","author":"Y Jin","year":"2023","unstructured":"Jin Y, et al. A novel \u201cinside-out\u201d intraocular nanomedicine delivery mode for nanomaterials\u2019 biological effect enhanced choroidal neovascularization occlusion and microenvironment regulation. Adv Mater. 2023;35(10): e2209690.","journal-title":"Adv Mater"},{"key":"3095_CR169","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102836","volume":"65","author":"L Su","year":"2023","unstructured":"Su L, et al. Mechanism of action of platinum nanoparticles implying from antioxidant to metabolic programming in light-induced retinal degeneration model. Redox Biol. 2023;65: 102836.","journal-title":"Redox Biol"},{"issue":"22","key":"3095_CR170","doi-asserted-by":"publisher","first-page":"22800","DOI":"10.1021\/acsnano.3c07517","volume":"17","author":"S Cupini","year":"2023","unstructured":"Cupini S, et al. Platinum nanozymes counteract photoreceptor degeneration and retina inflammation in a light-damage model of age-related macular degeneration. ACS Nano. 2023;17(22):22800\u201320.","journal-title":"ACS Nano"},{"issue":"7","key":"3095_CR171","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.7150\/thno.78426","volume":"13","author":"SK Reddy","year":"2023","unstructured":"Reddy SK, et al. Small extracellular vesicle-loaded bevacizumab reduces the frequency of intravitreal injection required for diabetic retinopathy. Theranostics. 2023;13(7):2241\u201355.","journal-title":"Theranostics"},{"key":"3095_CR172","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102911","volume":"67","author":"Z Cha","year":"2023","unstructured":"Cha Z, et al. Fullerol rescues the light-induced retinal damage by modulating M\u00fcller glia cell fate. Redox Biol. 2023;67: 102911.","journal-title":"Redox Biol"},{"key":"3095_CR173","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.jconrel.2023.11.035","volume":"365","author":"F Manai","year":"2024","unstructured":"Manai F, et al. Extracellular vesicles in degenerative retinal diseases: A new therapeutic paradigm. J Control Release. 2024;365:448\u201368.","journal-title":"J Control Release"},{"key":"3095_CR174","doi-asserted-by":"publisher","DOI":"10.3390\/cells13020144","author":"PP Mart\u00ednez-Rojas","year":"2024","unstructured":"Mart\u00ednez-Rojas PP, et al. Zika virus-infected monocyte exosomes mediate cell-to-cell viral transmission. Cells. 2024. https:\/\/doi.org\/10.3390\/cells13020144.","journal-title":"Cells"},{"issue":"1","key":"3095_CR175","doi-asserted-by":"publisher","first-page":"3482","DOI":"10.1038\/s41598-019-39861-4","volume":"9","author":"Y van der Merwe","year":"2019","unstructured":"van der Merwe Y, et al. Matrix-bound nanovesicles prevent ischemia-induced retinal ganglion cell axon degeneration and death and preserve visual function. Sci Rep. 2019;9(1):3482.","journal-title":"Sci Rep"},{"issue":"1","key":"3095_CR176","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41536-024-00374-y","volume":"9","author":"GP Campbell","year":"2024","unstructured":"Campbell GP, et al. Immunomodulation by the combination of statin and matrix-bound nanovesicle enhances optic nerve regeneration. NPJ Regen Med. 2024;9(1):31.","journal-title":"NPJ Regen Med"},{"issue":"46","key":"3095_CR177","doi-asserted-by":"publisher","DOI":"10.1002\/smll.202302962","volume":"19","author":"Y Liu","year":"2023","unstructured":"Liu Y, et al. Engineered extracellular vesicles for delivery of an IL-1 receptor antagonist promote targeted repair of retinal degeneration. Small. 2023;19(46): e2302962.","journal-title":"Small"},{"key":"3095_CR178","first-page":"444","volume":"33","author":"F Sun","year":"2024","unstructured":"Sun F, et al. Engineered mesenchymal stem cell-derived small extracellular vesicles for diabetic retinopathy therapy through HIF-1\u03b1\/EZH2\/PGC-1\u03b1 pathway. Bioact Mater. 2024;33:444\u201359.","journal-title":"Bioact Mater"},{"issue":"1","key":"3095_CR179","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s12951-023-02225-2","volume":"21","author":"Y Sun","year":"2023","unstructured":"Sun Y, et al. Hypoxic preconditioned MSCs-derived small extracellular vesicles for photoreceptor protection in retinal degeneration. J Nanobiotechnology. 2023;21(1):449.","journal-title":"J Nanobiotechnology"},{"issue":"10","key":"3095_CR180","doi-asserted-by":"publisher","first-page":"2315","DOI":"10.4103\/1673-5374.369123","volume":"18","author":"TQ Duan","year":"2023","unstructured":"Duan TQ, et al. Adipose mesenchymal stem cell-derived extracellular vesicles reduce glutamate-induced excitotoxicity in the retina. Neural Regen Res. 2023;18(10):2315\u201320.","journal-title":"Neural Regen Res"},{"issue":"9","key":"3095_CR181","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/s41551-021-00764-3","volume":"5","author":"Y Tian","year":"2021","unstructured":"Tian Y, et al. Reduction of choroidal neovascularization via cleavable VEGF antibodies conjugated to exosomes derived from regulatory T cells. Nat Biomed Eng. 2021;5(9):968\u201382.","journal-title":"Nat Biomed Eng"},{"key":"3095_CR182","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.jconrel.2024.04.036","volume":"370","author":"S Huang","year":"2024","unstructured":"Huang S, et al. Small extracellular vesicles of organoid-derived human retinal stem cells remodel M\u00fcller cell fate via miRNA: a novel remedy for retinal degeneration. J Control Release. 2024;370:405\u201320.","journal-title":"J Control Release"},{"key":"3095_CR183","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1038\/s41551-023-01112-3","volume":"11","author":"H Bao","year":"2023","unstructured":"Bao H, et al. Exosome-loaded degradable polymeric microcapsules for the treatment of vitreoretinal diseases. Nat Biomed Eng. 2023;11:1436.","journal-title":"Nat Biomed Eng"},{"issue":"11","key":"3095_CR184","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1007\/s00417-018-4097-3","volume":"256","author":"X Zhang","year":"2018","unstructured":"Zhang X, et al. Effects of mesenchymal stem cells and their exosomes on the healing of large and refractory macular holes. Graefes Arch Clin Exp Ophthalmol. 2018;256(11):2041\u201352.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"11","key":"3095_CR185","doi-asserted-by":"publisher","first-page":"19412","DOI":"10.1021\/acsnano.2c09087","volume":"16","author":"YS Kwon","year":"2022","unstructured":"Kwon YS, et al. Melanin-like nanoparticles as an alternative to natural melanin in retinal pigment epithelium cells and their therapeutic effects against age-related macular degeneration. ACS Nano. 2022;16(11):19412\u201322.","journal-title":"ACS Nano"},{"issue":"1","key":"3095_CR186","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1186\/s12951-021-01199-3","volume":"19","author":"X Lou","year":"2021","unstructured":"Lou X, et al. Polydopamine nanoparticles attenuate retina ganglion cell degeneration and restore visual function after optic nerve injury. J Nanobiotechnology. 2021;19(1):436.","journal-title":"J Nanobiotechnology"},{"key":"3095_CR187","doi-asserted-by":"publisher","first-page":"2308635","DOI":"10.1002\/advs.202308635","volume":"11","author":"YC Liu","year":"2024","unstructured":"Liu YC, et al. Injectable, antioxidative, and tissue-adhesive nanocomposite hydrogel as a potential treatment for inner retina injuries. Adv Sci. 2024;11:2308635.","journal-title":"Adv Sci"},{"issue":"6","key":"3095_CR188","doi-asserted-by":"publisher","first-page":"9808","DOI":"10.1021\/acsnano.1c00680","volume":"15","author":"M Li","year":"2021","unstructured":"Li M, et al. Targeted noninvasive treatment of choroidal neovascularization by hybrid cell-membrane-cloaked biomimetic nanoparticles. ACS Nano. 2021;15(6):9808\u201319.","journal-title":"ACS Nano"},{"issue":"6","key":"3095_CR189","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s13770-023-00555-8","volume":"20","author":"SW Choi","year":"2023","unstructured":"Choi SW, et al. Therapeutic extracellular vesicles from tonsil-derived mesenchymal stem cells for the treatment of retinal degenerative disease. Tissue Eng Regen Med. 2023;20(6):951\u201364.","journal-title":"Tissue Eng Regen Med"},{"key":"3095_CR190","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2019.119603","volume":"230","author":"K Ben M'Barek","year":"2020","unstructured":"Ben M\u2019Barek K, et al. Clinical-grade production and safe delivery of human ESC derived RPE sheets in primates and rodents. Biomaterials. 2020;230: 119603.","journal-title":"Biomaterials"},{"issue":"2","key":"3095_CR191","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.cell.2022.12.022","volume":"186","author":"W Nyberg","year":"2023","unstructured":"Nyberg W, et al. An evolved AAV variant enables efficient genetic engineering of murine T cells. Cell. 2023;186(2):446-460.e19.","journal-title":"Cell"},{"key":"3095_CR192","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jconrel.2023.05.033","volume":"359","author":"L Narsineni","year":"2023","unstructured":"Narsineni L, Chen DW, Foldvari M. BDNF gene delivery to the retina by cell adhesion peptide-conjugated gemini nanoplexes in vivo. J Control Release. 2023;359:244\u201356.","journal-title":"J Control Release"},{"issue":"2","key":"3095_CR193","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2024.102222","volume":"35","author":"R Crane","year":"2024","unstructured":"Crane R, et al. Effective intravitreal gene delivery to retinal pigment epithelium with hyaluronic acid nanospheres. Mol Ther Nucleic Acids. 2024;35(2): 102222.","journal-title":"Mol Ther Nucleic Acids"},{"key":"3095_CR194","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jconrel.2019.04.015","volume":"303","author":"S Patel","year":"2019","unstructured":"Patel S, et al. Lipid nanoparticles for delivery of messenger RNA to the back of the eye. J Control Release. 2019;303:91\u2013100.","journal-title":"J Control Release"},{"issue":"1","key":"3095_CR195","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.ymthe.2019.09.010","volume":"28","author":"D Sun","year":"2020","unstructured":"Sun D, et al. Non-viral gene therapy for stargardt disease with ECO\/pRHO-ABCA4 self-assembled nanoparticles. Mol Ther. 2020;28(1):293\u2013303.","journal-title":"Mol Ther"},{"key":"3095_CR196","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jconrel.2020.12.010","volume":"330","author":"D Sun","year":"2021","unstructured":"Sun D, et al. Formulation and efficacy of ECO\/pRHO-ABCA4-SV40 nanoparticles for nonviral gene therapy of Stargardt disease in a mouse model. J Control Release. 2021;330:329\u201340.","journal-title":"J Control Release"},{"issue":"2","key":"3095_CR197","doi-asserted-by":"publisher","first-page":"eadd4623","DOI":"10.1126\/sciadv.add4623","volume":"9","author":"M Herrera-Barrera","year":"2023","unstructured":"Herrera-Barrera M, et al. Peptide-guided lipid nanoparticles deliver mRNA to the neural retina of rodents and nonhuman primates. Sci Adv. 2023;9(2):eadd4623.","journal-title":"Sci Adv"},{"issue":"1","key":"3095_CR198","doi-asserted-by":"publisher","first-page":"6468","DOI":"10.1038\/s41467-023-42189-3","volume":"14","author":"M Gautam","year":"2023","unstructured":"Gautam M, et al. Lipid nanoparticles with PEG-variant surface modifications mediate genome editing in the mouse retina. Nat Commun. 2023;14(1):6468.","journal-title":"Nat Commun"},{"key":"3095_CR199","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.actbio.2021.07.053","volume":"134","author":"G Tan","year":"2021","unstructured":"Tan G, et al. A core-shell nanoplatform as a nonviral vector for targeted delivery of genes to the retina. Acta Biomater. 2021;134:605\u201320.","journal-title":"Acta Biomater"},{"issue":"10","key":"3095_CR200","doi-asserted-by":"publisher","first-page":"1903432","DOI":"10.1002\/advs.201903432","volume":"7","author":"S Chou","year":"2020","unstructured":"Chou S, et al. Dual supramolecular nanoparticle vectors enable CRISPR\/Cas9-mediated knockin of retinoschisin 1 gene-a potential nonviral therapeutic solution for X-linked juvenile retinoschisis. Adv Sci. 2020;7(10):1903432.","journal-title":"Adv Sci"},{"key":"3095_CR201","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.jconrel.2022.08.006","volume":"350","author":"K Huang","year":"2022","unstructured":"Huang K, et al. Immunomodulation of MiRNA-223-based nanoplatform for targeted therapy in retinopathy of prematurity. J Control Release. 2022;350:789\u2013802.","journal-title":"J Control Release"},{"key":"3095_CR202","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/jcm11082170","volume":"11","author":"L Vald\u00e9s-S\u00e1nchez","year":"2022","unstructured":"Vald\u00e9s-S\u00e1nchez L, et al. Mesoporous silica-based nanoparticles as non-viral gene delivery platform for treating retinitis pigmentosa. J Clin Med. 2022;11:8.","journal-title":"J Clin Med"},{"key":"3095_CR203","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jconrel.2020.04.052","volume":"324","author":"Y Wang","year":"2020","unstructured":"Wang Y, et al. A pH-responsive silica-metal-organic framework hybrid nanoparticle for the delivery of hydrophilic drugs, nucleic acids, and CRISPR-Cas9 genome-editing machineries. J Control Release. 2020;324:194\u2013203.","journal-title":"J Control Release"},{"key":"3095_CR204","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.jconrel.2021.06.030","volume":"336","author":"Y Wang","year":"2021","unstructured":"Wang Y, et al. In vivo targeted delivery of nucleic acids and CRISPR genome editors enabled by GSH-responsive silica nanoparticles. J Control Release. 2021;336:296\u2013309.","journal-title":"J Control Release"},{"key":"3095_CR205","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1172\/JCI171356","volume":"133","author":"M Kabra","year":"2023","unstructured":"Kabra M, et al. Nonviral base editing of KCNJ13 mutation preserves vision in a model of inherited retinal channelopathy. J Clin Invest. 2023;133:19.","journal-title":"J Clin Invest"},{"issue":"4","key":"3095_CR206","first-page":"990","volume":"6","author":"N Sun","year":"2021","unstructured":"Sun N, et al. Bio-inspired chiral self-assemblies promoted neuronal differentiation of retinal progenitor cells through activation of metabolic pathway. Bioact Mater. 2021;6(4):990\u20137.","journal-title":"Bioact Mater"},{"issue":"20","key":"3095_CR207","doi-asserted-by":"publisher","first-page":"5938","DOI":"10.1039\/D2BM00886F","volume":"10","author":"N Sun","year":"2022","unstructured":"Sun N, et al. A chiral microenvironment promotes retinal progenitor cell proliferation by activating the Akt and ERK pathways. Biomater Sci. 2022;10(20):5938\u201346.","journal-title":"Biomater Sci"},{"key":"3095_CR208","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1089\/ten.tea.2019.0007","volume":"25","author":"A Garc\u00eda Delgado","year":"2019","unstructured":"Garc\u00eda Delgado A, et al. Subretinal transplant of induced pluripotent stem cell-derived retinal pigment epithelium on nanostructured fibrin-agarose. Tissue Eng Part A. 2019;25:799\u2013808.","journal-title":"Tissue Eng Part A"},{"key":"3095_CR209","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.actbio.2024.05.001","volume":"181","author":"K Kawai","year":"2024","unstructured":"Kawai K, et al. Hyaluronan improves photoreceptor differentiation and maturation in human retinal organoids. Acta Biomater. 2024;181:117\u201332.","journal-title":"Acta Biomater"},{"key":"3095_CR210","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.120233","volume":"257","author":"N Mitrousis","year":"2020","unstructured":"Mitrousis N, et al. Hydrogel-mediated co-transplantation of retinal pigmented epithelium and photoreceptors restores vision in an animal model of advanced retinal degeneration. Biomaterials. 2020;257: 120233.","journal-title":"Biomaterials"},{"issue":"6","key":"3095_CR211","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1039\/C8BM01579A","volume":"7","author":"F Jiang","year":"2019","unstructured":"Jiang F, et al. Enhanced proliferation and differentiation of retinal progenitor cells through a self-healing injectable hydrogel. Biomater Sci. 2019;7(6):2335\u201347.","journal-title":"Biomater Sci"},{"key":"3095_CR212","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.biomaterials.2018.12.015","volume":"194","author":"Z Tang","year":"2019","unstructured":"Tang Z, et al. Mussel-inspired injectable hydrogel and its counterpart for actuating proliferation and neuronal differentiation of retinal progenitor cells. Biomaterials. 2019;194:57\u201372.","journal-title":"Biomaterials"},{"issue":"8","key":"3095_CR213","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.1007\/s12015-023-10622-1","volume":"19","author":"J Ma","year":"2023","unstructured":"Ma J, et al. Hyaluronan-CD44 interaction regulates mouse retinal progenitor cells migration, proliferation and neuronal differentiation. Stem Cell Rev Rep. 2023;19(8):2929\u201342.","journal-title":"Stem Cell Rev Rep"},{"key":"3095_CR214","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27175512","author":"J Youn","year":"2022","unstructured":"Youn J, et al. Fabrication and evaluation of gellan gum\/hyaluronic acid hydrogel for retinal tissue engineering biomaterial and the influence of substrate stress relaxation on retinal pigment epithelial cells. Molecules. 2022. https:\/\/doi.org\/10.3390\/molecules27175512.","journal-title":"Molecules"},{"issue":"45","key":"3095_CR215","doi-asserted-by":"publisher","first-page":"41331","DOI":"10.1021\/acsomega.2c05113","volume":"7","author":"SI Kim","year":"2022","unstructured":"Kim SI, et al. Injectable hydrogel based on gellan gum\/silk sericin for application as a retinal pigment epithelium cell carrier. ACS Omega. 2022;7(45):41331\u201340.","journal-title":"ACS Omega"},{"issue":"2","key":"3095_CR216","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1021\/acsabm.0c01516","volume":"4","author":"W Lee","year":"2021","unstructured":"Lee W, et al. Dopamine-functionalized gellan gum hydrogel as a candidate biomaterial for a retinal pigment epithelium cell delivery system. ACS Appl Bio Mater. 2021;4(2):1771\u201382.","journal-title":"ACS Appl Bio Mater"},{"key":"3095_CR217","doi-asserted-by":"publisher","DOI":"10.1016\/j.actbio.2024.10.023","author":"K Chang","year":"2024","unstructured":"Chang K, et al. Bioengineering strategy to promote CNS nerve growth and regeneration via chronic glutamate signaling. Acta Biomater. 2024. https:\/\/doi.org\/10.1016\/j.actbio.2024.10.023.","journal-title":"Acta Biomater"},{"key":"3095_CR218","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.actbio.2019.04.057","volume":"94","author":"J Thompson","year":"2019","unstructured":"Thompson J, et al. Two-photon polymerized poly(caprolactone) retinal cell delivery scaffolds and their systemic and retinal biocompatibility. Acta Biomater. 2019;94:204\u201318.","journal-title":"Acta Biomater"},{"key":"3095_CR219","doi-asserted-by":"publisher","DOI":"10.1088\/1748-605X\/ad1bae","author":"S Behtaj","year":"2024","unstructured":"Behtaj S, et al. Ciliary neurotrophic factor mediated growth of retinal ganglion cell axons on PGS\/PCL scaffolds. Biomed Mater. 2024. https:\/\/doi.org\/10.1088\/1748-605X\/ad1bae.","journal-title":"Biomed Mater"},{"key":"3095_CR220","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abf0344","author":"IK Lee","year":"2021","unstructured":"Lee IK, et al. Ultrathin micromolded 3D scaffolds for high-density photoreceptor layer reconstruction. Sci Adv. 2021. https:\/\/doi.org\/10.1126\/sciadv.abf0344.","journal-title":"Sci Adv"},{"issue":"17","key":"3095_CR221","doi-asserted-by":"publisher","first-page":"3167","DOI":"10.1021\/acschemneuro.1c00242","volume":"12","author":"R Yang","year":"2021","unstructured":"Yang R, et al. Carbon nanotube polymer scaffolds as a conductive alternative for the construction of retinal sheet tissue. ACS Chem Neurosci. 2021;12(17):3167\u201375.","journal-title":"ACS Chem Neurosci"},{"key":"3095_CR222","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302747","author":"Z Tang","year":"2023","unstructured":"Tang Z, et al. Bifunctional MXene-augmented retinal progenitor cell transplantation for retinal degeneration. Adv Sci. 2023. https:\/\/doi.org\/10.1002\/advs.202302747.","journal-title":"Adv Sci"},{"key":"3095_CR223","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2023.122140","volume":"298","author":"MT Ho","year":"2023","unstructured":"Ho MT, et al. Hydrogel assisted photoreceptor delivery inhibits material transfer. Biomaterials. 2023;298: 122140.","journal-title":"Biomaterials"},{"issue":"7","key":"3095_CR224","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1038\/s41591-021-01351-4","volume":"27","author":"JA Sahel","year":"2021","unstructured":"Sahel JA, et al. Partial recovery of visual function in a blind patient after optogenetic therapy. Nat Med. 2021;27(7):1223\u20139.","journal-title":"Nat Med"},{"issue":"1","key":"3095_CR225","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41467-020-15317-6","volume":"11","author":"JE McGregor","year":"2020","unstructured":"McGregor JE, et al. Optogenetic restoration of retinal ganglion cell activity in the living primate. Nat Commun. 2020;11(1):1703.","journal-title":"Nat Commun"},{"issue":"11","key":"3095_CR226","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1038\/s41587-022-01351-w","volume":"40","author":"Y Kuwasaki","year":"2022","unstructured":"Kuwasaki Y, et al. A red light-responsive photoswitch for deep tissue optogenetics. Nat Biotechnol. 2022;40(11):1672\u20139.","journal-title":"Nat Biotechnol"},{"issue":"16","key":"3095_CR227","doi-asserted-by":"publisher","first-page":"6825","DOI":"10.1021\/acs.nanolett.2c01685","volume":"22","author":"B Park","year":"2022","unstructured":"Park B, et al. Photosensitive nanodiscs composed of human photoreceptors for refractive index modulation at selective wavelengths. Nano Lett. 2022;22(16):6825\u201332.","journal-title":"Nano Lett"},{"key":"3095_CR228","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202101310","author":"C Chu","year":"2021","unstructured":"Chu C, et al. Flexible optogenetic transducer device for remote neuron modulation using highly upconversion-efficient dendrite-like gold inverse opaline structure. Adv Healthc Mater. 2021. https:\/\/doi.org\/10.1002\/adhm.202101310.","journal-title":"Adv Healthc Mater"},{"key":"3095_CR229","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.add7526","author":"CJ Shih","year":"2023","unstructured":"Shih CJ, et al. Transparent organic upconversion devices displaying high-resolution, single-pixel, low-power infrared images perceived by human vision. Sci Adv. 2023. https:\/\/doi.org\/10.1126\/sciadv.add7526.","journal-title":"Sci Adv"},{"issue":"6495","key":"3095_CR230","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1126\/science.aaz5887","volume":"368","author":"D Nelidova","year":"2020","unstructured":"Nelidova D, et al. Restoring light sensitivity using tunable near-infrared sensors. Science. 2020;368(6495):1108\u201313.","journal-title":"Science"},{"key":"3095_CR231","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.actbio.2023.01.017","volume":"158","author":"J Yang","year":"2023","unstructured":"Yang J, et al. Upconversion optogenetics-driven biohybrid sensor for infrared sensing and imaging. Acta Biomater. 2023;158:747\u201358.","journal-title":"Acta Biomater"},{"issue":"1","key":"3095_CR232","doi-asserted-by":"publisher","first-page":"5662","DOI":"10.1038\/s41467-021-25993-7","volume":"12","author":"X Liu","year":"2021","unstructured":"Liu X, et al. Near-infrared manipulation of multiple neuronal populations via trichromatic upconversion. Nat Commun. 2021;12(1):5662.","journal-title":"Nat Commun"},{"issue":"3","key":"3095_CR233","doi-asserted-by":"publisher","first-page":"2502","DOI":"10.1021\/acsabm.0c01465","volume":"4","author":"J Li","year":"2021","unstructured":"Li J, et al. CRISPR-dcas9 optogenetic nanosystem for the blue light-mediated treatment of neovascular lesions. ACS Appl Bio Mater. 2021;4(3):2502\u201313.","journal-title":"ACS Appl Bio Mater"},{"issue":"8","key":"3095_CR234","doi-asserted-by":"publisher","first-page":"7750","DOI":"10.1021\/acsnano.3c00470","volume":"17","author":"J Ding","year":"2023","unstructured":"Ding J, et al. Camouflage nanoparticles enable in situ bioluminescence-driven optogenetic therapy of retinoblastoma. ACS Nano. 2023;17(8):7750\u201364.","journal-title":"ACS Nano"},{"key":"3095_CR235","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202207038","author":"S Bi","year":"2022","unstructured":"Bi S, et al. NIR-II responsive upconversion nanoprobe with simultaneously enhanced single-band red luminescence and phase\/size control for bioimaging and photodynamic therapy. Adv Mater. 2022. https:\/\/doi.org\/10.1002\/adma.202207038.","journal-title":"Adv Mater"},{"key":"3095_CR236","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-021-00836-4","author":"J Cehajic-Kapetanovic","year":"2022","unstructured":"Cehajic-Kapetanovic J, et al. Bioengineering strategies for restoring vision. Nat Biomed Eng. 2022. https:\/\/doi.org\/10.1038\/s41551-021-00836-4.","journal-title":"Nat Biomed Eng"},{"issue":"12","key":"3095_CR237","doi-asserted-by":"publisher","first-page":"7440","DOI":"10.1167\/iovs.12-9612","volume":"53","author":"L Naycheva","year":"2012","unstructured":"Naycheva L, et al. Phosphene thresholds elicited by transcorneal electrical stimulation in healthy subjects and patients with retinal diseases. Invest Ophthalmol Vis Sci. 2012;53(12):7440\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"3095_CR238","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1167\/iovs.16-19906","volume":"58","author":"A Schatz","year":"2017","unstructured":"Schatz A, et al. Transcorneal electrical stimulation for patients with retinitis pigmentosa: a prospective, randomized, sham-controlled follow-up study over 1 year. Invest Ophthalmol Vis Sci. 2017;58(1):257\u201369.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"3095_CR239","doi-asserted-by":"publisher","first-page":"617","DOI":"10.2217\/nnm-2020-0471","volume":"16","author":"TL Jackson","year":"2021","unstructured":"Jackson TL, et al. Intravitreal quantum dots for retinitis pigmentosa: a first-in-human safety study. Nanomedicine. 2021;16(8):617\u201326.","journal-title":"Nanomedicine"},{"issue":"8","key":"3095_CR240","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41565-020-0696-3","volume":"15","author":"JF Maya-Vetencourt","year":"2020","unstructured":"Maya-Vetencourt JF, et al. Subretinally injected semiconducting polymer nanoparticles rescue vision in a rat model of retinal dystrophy. Nat Nanotechnol. 2020;15(8):698\u2013708.","journal-title":"Nat Nanotechnol"},{"issue":"1","key":"3095_CR241","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1038\/s41467-022-31368-3","volume":"13","author":"S Francia","year":"2022","unstructured":"Francia S, et al. Light-induced charge generation in polymeric nanoparticles restores vision in advanced-stage retinitis pigmentosa rats. Nat Commun. 2022;13(1):3677.","journal-title":"Nat Commun"},{"issue":"16","key":"3095_CR242","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202300120","volume":"10","author":"M Huang","year":"2023","unstructured":"Huang M, et al. Multifunctional optoelectronic synapses based on arrayed MoS(2) monolayers emulating human association memory. Adv Sci. 2023;10(16): e2300120.","journal-title":"Adv Sci"},{"issue":"28","key":"3095_CR243","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202300446","volume":"35","author":"D Kumar","year":"2023","unstructured":"Kumar D, et al. Flexible solution-processable black-phosphorus-based optoelectronic memristive synapses for neuromorphic computing and artificial visual perception applications. Adv Mater. 2023;35(28): e2300446.","journal-title":"Adv Mater"},{"issue":"6","key":"3095_CR244","doi-asserted-by":"publisher","DOI":"10.1002\/smtd.202201679","volume":"7","author":"Y Yan","year":"2023","unstructured":"Yan Y, et al. Optoelectronic synaptic memtransistor based on 2D SnSe\/MoS(2) van der waals heterostructure under UV-Ozone treatment. Small Methods. 2023;7(6): e2201679.","journal-title":"Small Methods"},{"issue":"24","key":"3095_CR245","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202301468","volume":"35","author":"X Zhu","year":"2023","unstructured":"Zhu X, et al. High-contrast bidirectional optoelectronic synapses based on 2d molecular crystal heterojunctions for motion detection. Adv Mater. 2023;35(24): e2301468.","journal-title":"Adv Mater"},{"issue":"7","key":"3095_CR246","doi-asserted-by":"publisher","DOI":"10.1002\/smtd.202201719","volume":"7","author":"Y Hwang","year":"2023","unstructured":"Hwang Y, et al. A bioinspired ultra flexible artificial van der Waals 2D-MoS(2) Channel\/LiSiO(x) solid electrolyte synapse arrays via laser-lift off process for wearable adaptive neuromorphic computing. Small Methods. 2023;7(7): e2201719.","journal-title":"Small Methods"},{"key":"3095_CR247","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.2c06921","author":"N Li","year":"2023","unstructured":"Li N, et al. 2D Semiconductor based flexible photoresponsive ring oscillators for artificial vision pixels. ACS Nano. 2023. https:\/\/doi.org\/10.1021\/acsnano.2c06921.","journal-title":"ACS Nano"},{"key":"3095_CR248","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-023-01137-8","author":"R Yang","year":"2023","unstructured":"Yang R, et al. Assessment of visual function in blind mice and monkeys with subretinally implanted nanowire arrays as artificial photoreceptors. Nat Biomed Eng. 2023. https:\/\/doi.org\/10.1038\/s41551-023-01137-8.","journal-title":"Nat Biomed Eng"},{"key":"3095_CR249","doi-asserted-by":"publisher","DOI":"10.1002\/EXP.20220146","author":"DM Zheng","year":"2024","unstructured":"Zheng DM, et al. Models of light absorption enhancement in perovskite solar cells by plasmonic nanoparticles. Exploration. 2024. https:\/\/doi.org\/10.1002\/EXP.20220146.","journal-title":"Exploration"},{"issue":"52","key":"3095_CR250","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202104960","volume":"33","author":"Y Hu","year":"2021","unstructured":"Hu Y, et al. Ultralow power optical synapses based on MoS(2) layers by indium-induced surface charge doping for biomimetic eyes. Adv Mater. 2021;33(52): e2104960.","journal-title":"Adv Mater"},{"issue":"16","key":"3095_CR251","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202100742","volume":"8","author":"CC Hung","year":"2021","unstructured":"Hung CC, et al. Conception of a smart artificial retina based on a dual-mode organic sensing inverter. Adv Sci. 2021;8(16): e2100742.","journal-title":"Adv Sci"},{"issue":"15","key":"3095_CR252","doi-asserted-by":"publisher","first-page":"eade2338","DOI":"10.1126\/sciadv.ade2338","volume":"9","author":"Y Hou","year":"2023","unstructured":"Hou Y, et al. Retina-inspired narrowband perovskite sensor array for panchromatic imaging. Sci Adv. 2023;9(15):eade2338.","journal-title":"Sci Adv"},{"issue":"1","key":"3095_CR253","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1038\/s41467-023-37581-y","volume":"14","author":"Z Long","year":"2023","unstructured":"Long Z, et al. A neuromorphic bionic eye with filter-free color vision using hemispherical perovskite nanowire array retina. Nat Commun. 2023;14(1):1972.","journal-title":"Nat Commun"},{"issue":"1","key":"3095_CR254","doi-asserted-by":"publisher","first-page":"3086","DOI":"10.1038\/s41467-024-47374-6","volume":"15","author":"X Luo","year":"2024","unstructured":"Luo X, et al. A bionic self-driven retinomorphic eye with ionogel photosynaptic retina. Nat Commun. 2024;15(1):3086.","journal-title":"Nat Commun"},{"key":"3095_CR255","doi-asserted-by":"publisher","DOI":"10.1038\/s41565-023-01587-w","author":"WG Chung","year":"2024","unstructured":"Chung WG, et al. Liquid-metal-based three-dimensional microelectrode arrays integrated with implantable ultrathin retinal prosthesis for vision restoration. Nat Nanotechnol. 2024. https:\/\/doi.org\/10.1038\/s41565-023-01587-w.","journal-title":"Nat Nanotechnol"},{"issue":"8","key":"3095_CR256","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.ophtha.2020.02.024","volume":"127","author":"D Palanker","year":"2020","unstructured":"Palanker D, et al. Photovoltaic restoration of central vision in atrophic age-related macular degeneration. Ophthalmology. 2020;127(8):1097\u2013104.","journal-title":"Ophthalmology"},{"issue":"7","key":"3095_CR257","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1111\/aos.14443","volume":"98","author":"J Cehajic Kapetanovic","year":"2020","unstructured":"Cehajic Kapetanovic J, et al. Highest reported visual acuity after electronic retinal implantation. Acta Ophthalmol. 2020;98(7):736\u201340.","journal-title":"Acta Ophthalmol"},{"issue":"8","key":"3095_CR258","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1001\/jamaophthalmol.2019.1476","volume":"137","author":"K Schaffrath","year":"2019","unstructured":"Schaffrath K, et al. One-year safety and performance assessment of the argus II retinal prosthesis: a postapproval study. JAMA Ophthalmol. 2019;137(8):896\u2013902.","journal-title":"JAMA Ophthalmol"},{"issue":"6","key":"3095_CR259","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1016\/j.clinph.2019.11.029","volume":"131","author":"LN Ayton","year":"2020","unstructured":"Ayton LN, et al. An update on retinal prostheses. Clin Neurophysiol. 2020;131(6):1383\u201398.","journal-title":"Clin Neurophysiol"},{"issue":"1","key":"3095_CR260","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41467-022-28125-x","volume":"13","author":"D Palanker","year":"2022","unstructured":"Palanker D, et al. Simultaneous perception of prosthetic and natural vision in AMD patients. Nat Commun. 2022;13(1):513.","journal-title":"Nat Commun"},{"issue":"2","key":"3095_CR261","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.apsb.2023.09.001","volume":"14","author":"S Guo","year":"2024","unstructured":"Guo S, et al. pH-Responsive polymer boosts cytosolic siRNA release for retinal neovascularization therapy. Acta Pharm Sin B. 2024;14(2):781\u201394.","journal-title":"Acta Pharm Sin B"},{"issue":"12","key":"3095_CR262","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/s41578-023-00581-x","volume":"8","author":"PJ Gawne","year":"2023","unstructured":"Gawne PJ, et al. New opportunities and old challenges in the clinical translation of nanotheranostics. Nat Rev Mater. 2023;8(12):783\u201398.","journal-title":"Nat Rev Mater"},{"issue":"1","key":"3095_CR263","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12951-022-01326-8","volume":"20","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, et al. Mechanistic study of silica nanoparticles on the size-dependent retinal toxicity in vitro and in vivo. J Nanobiotechnology. 2022;20(1):146.","journal-title":"J Nanobiotechnology"},{"key":"3095_CR264","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.114022","volume":"180","author":"R Mohammapdour","year":"2022","unstructured":"Mohammapdour R, Ghandehari H. Mechanisms of immune response to inorganic nanoparticles and their degradation products. Adv Drug Deliv Rev. 2022;180: 114022.","journal-title":"Adv Drug Deliv Rev"},{"key":"3095_CR265","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1021\/acsnano.2c05447","volume":"2","author":"A Badia","year":"2023","unstructured":"Badia A, et al. Repeated topical administration of 3 nm cerium oxide nanoparticles reverts disease atrophic phenotype and arrests neovascular degeneration in amd mouse models. ACS Nano. 2023;2:910.","journal-title":"ACS Nano"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03095-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03095-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03095-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T16:46:45Z","timestamp":1740502005000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03095-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,25]]},"references-count":265,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3095"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03095-6","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,25]]},"assertion":[{"value":"16 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent to this publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"143"}}